BDX vs EXEL · P/E 34, rev $21.84B vs P/E 17, rev $1.24B
Becton Dickinson and Company (BDX) versus Exelixis Inc (EXEL) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported EXEL revenue for 2026-07-03 was $1.24B. Net income was $422.5M. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Not investment advice. Open the BDX and EXEL stock pages for the full models.
Not investment advice.